FSMAX
Price
$94.35
Change
+$0.25 (+0.27%)
Updated
Jul 8 closing price
Net Assets
39.17B
PQCCX
Price
$9.71
Change
+$0.04 (+0.41%)
Updated
Jul 8 closing price
Net Assets
13.17M
Interact to see
Advertisement

FSMAX vs PQCCX

Header iconFSMAX vs PQCCX Comparison
Open Charts FSMAX vs PQCCXBanner chart's image
Fidelity Extended Market Index
Price$94.35
Change+$0.25 (+0.27%)
VolumeN/A
Net Assets39.17B
PGIM Quant Solutions Mid-Cap Index R6
Price$9.71
Change+$0.04 (+0.41%)
VolumeN/A
Net Assets13.17M
FSMAX vs PQCCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMAX vs. PQCCX commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a StrongBuy and PQCCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 39.2B vs. PQCCX (13.2M). PQCCX pays higher dividends than FSMAX: PQCCX (1.26) vs FSMAX (0.47). FSMAX was incepted earlier than PQCCX: FSMAX (14 years) vs PQCCX (9 years). PQCCX (1.71) is less costly to investors than FSMAX (0.04). PQCCX is a more actively managed with annual turnover of: 169.00 vs. FSMAX (9.00). FSMAX (0) and PQCCX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 17.37 vs. PQCCX (-6.54). FSMAX return over 5 years is better than : 62.84 vs. PQCCX (10.69).
FSMAXPQCCXFSMAX / PQCCX
Total Expense Ratio0.040.2018%
Annual Report Gross Expense Ratio0.041.712%
Fund Existence14 years9 years-
Gain YTD3.5431.682211%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets39.2B13.2M296,970%
Annual Yield % from dividends0.471.2638%
Returns for 1 year17.37-6.54-266%
Returns for 3 years49.150.2519,353%
Returns for 5 years62.8410.69588%
Returns for 10 years79.02N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GANX1.680.08
+5.00%
Gain Therapeutics
VSQTF0.17N/A
+0.39%
Victory Square Technologies Inc
LCSHF7.59N/A
N/A
Lancashire Holdings Ltd.
TAOFF3.05N/A
N/A
IPERIONX LTD.
IMDZF127.82N/A
N/A
IMCD NV